Speakers - Lunch & Learn 2017

New Jersey Lunch & Learn, 2017

Aravind Prasad

Scientist 1, Computational Chemistry

Celgene

Aravind Prasad is a Bioinformatics Scientist at Celgene in the Computational Chemistry group. He has previously worked in various capacities at major biotechnology companies as well as startups in the US and India.

At Celgene, Aravind supports New Target drug discovery efforts and is deeply involved in efforts to bring in silico technology solutions to drug discovery scientists. While he was at Avila Therapeutics, he developed the Avilomics™ covalent drug discovery platform that has successfully generated over a dozen development candidates so far. Prior to this he coordinated with a team of developers to build an Integrated Cheminformatics Expert System across global sites for a large pharma client. Aravind holds a Masters degree in Bioinformatics from Northeastern University and a bachelors degree in Electronic and Communications Engineering from Osmania University in India.
 

San Diego Lunch & Learn, 2017

Robert Coner

Associate Director, R&D Informatics

Peloton Therapeutics

Robert “Bob” Coner is currently Associate Director, R&D Informatics at Peloton Therapeutics. Bob previously worked for Pfizer for a decade and prior to that Eli Lilly. He implemented the Dotmatics system at Peloton Therapeutics in the early days of the company. Peloton Therapeutics is a clinical-stage biotechnology company that discovers and develops first-in-class, small molecule cancer therapies targeting unexploited molecular vulnerabilities.
 

George Lane

Research Informatics in Structural Chemistry

Gilead Sciences

George Lane earned a Bachelor of Science degree in Chemistry from the University of Rochester in 1997. His first position was at the combi chem library synthesis company SIDDCO where preparing electronic registration files to match the physical synthesis plates was his introduction to chemoinformatics. That led to a position at Sunesis, with more library registration and a variety of other responsibilities. At Gilead, George was instrumental in attempts to implement web based project analysis and view interfaces and identified and led to the adoption of Dotmatics as a research wide tool in 2009. Among George’s many other responsibilities are managing the data warehousing protocols and registration systems for the drug discovery programs at Gilead.
 

Dotmatics Symposium Cambridge, UK

Aravind Prasad

Scientist 1, Computational Chemistry

Celgene

Aravind Prasad is a Bioinformatics Scientist at Celgene in the Computational Chemistry group. He has previously worked in various capacities at major biotechnology companies as well as startups in the US and India.

At Celgene, Aravind supports New Target drug discovery efforts and is deeply involved in efforts to bring in silico technology solutions to drug discovery scientists. While he was at Avila Therapeutics, he developed the Avilomics™ covalent drug discovery platform that has successfully generated over a dozen development candidates so far. Prior to this he coordinated with a team of developers to build an Integrated Cheminformatics Expert System across global sites for a large pharma client. Aravind holds a Masters degree in Bioinformatics from Northeastern University and a bachelors degree in Electronic and Communications Engineering from Osmania University in India.
 

Oxford Lunch & Learn

Ray Boffey

Senior Medicinal Chemist

Domainex

Ray Boffey: Ray is a Medicinal Chemist Group Leader with 18 years experience and joined Domainex Ltd, a UK-based drug discovery CRO in 2010. He has lead numerous medicinal chemistry projects including target selection, HTS, hit identification and lead optimisation through to pre-candidate selection. Ray’s prior experience covers both academic and private sectors; including Argenta Discovery (Team leader, 6 years working with GSK, Lundbeck and Aventis), Lectus Therapeutics Ltd (senior medicinal chemist, 3 years) and Oxford Glycoscience (senior scientist, 2 years).
 

Jonny Wray

Head of Discovery Informatics

e-Therapeutics plc.

Jonny Wray is the Head of Discovery Informatics at e-Therapeutics and responsible for the conceptual formulation of their network-driven drug discovery approach and leads the team of computational experts responsible for the implementation of their in-silico discovery platform. He has over 25 years’ experience in the application of mathematical and computational techniques to the modelling and analysis of biological systems. Following post-doctoral work at the Neurosciences Institute moved into the biotechnology industry with positions of increasing responsibilities in bioinformatics and drug discovery informatics at Clontech and, most recently, Five Prime Therapeutics. Holds a PhD in computational biology from Newcastle University Medical School.
 

Request a demonstration or
ask us a question